Pharmacology’s Ruth Keri elected to Endocrine Society’s Board of Directors

Ruth Keri, professor of pharmacology and associate director for basic research in the Case Comprehensive Cancer Center has been elected to the Board of Directors for the Endocrine Society for a three-year term. 

The Endocrine Society has more than 18,000 members, including basic, translational and clinical investigators, as well as educators, nurses, and students in 122 countries. It is the world’s oldest and largest organization that focuses on hormones and hormone action, including the impact of hormones on cancer risk, treatment, and survival.

Read more about the appointment.